Literature DB >> 26553628

Prostate cancer: Effectiveness of abiraterone is unaffected by prior ADT.

Peter Sidaway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26553628     DOI： 10.1038/nrurol.2015.274

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies.

Authors:  Joaquim Bellmunt; Thian Kheoh; Margaret K Yu; Matthew R Smith; Eric J Small; Peter F A Mulders; Karim Fizazi; Dana E Rathkopf; Fred Saad; Howard I Scher; Mary-Ellen Taplin; Ian D Davis; Dirk Schrijvers; Andrew Protheroe; Arturo Molina; Peter De Porre; Thomas W Griffin; Johann S de Bono; Charles J Ryan; Stéphane Oudard
Journal:  Eur Urol       Date:  2015-10-24       Impact factor: 20.096
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.